HOOPER, LUNDY & BOOKMAN, P.C.
Lobbying for BRAINFUTURES · Nonprofit advocate for therapeutic treatments for mental health and substance use disorder
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, including reimbursement and workforce; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.
H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.